Clario, a healthcare research and technology company that delivers the leading endpoint technology solutions for clinical trials, has announced the acquisition of the technology company ArtiQ. This acquisition expands the power of artificial intelligence (AI) in Clario’s Respiratory Solutions portfolio and enhances the company’s ability to further leverage and develop innovative uses of AI across its service lines. In addition to the ArtiQ acquisition, Clario acquired Inofab Health, the manufacturer of easy-to-use ultrasonic sensor spirometer devices, in November 2023. Bringing these acquisitions together with Clario’s deep respiratory scientific capabilities will strengthen Clario’s Respiratory Solutions portfolio, serve as a launchpad for advancing AI within clinical trials, and increase its reach into the broader healthcare market.
Read the full article: Clario Announces Acquisition of AI-Powered Software Company ArtiQ //
Source: https://www.prnewswire.com/news-releases/clario-announces-acquisition-of-ai-powered-software-company-artiq-302104748.html